A fluid infusion device, for delivery of a medication fluid to the body of a user, includes a housing, a fluid reservoir for the medication fluid, a dosing mechanism, an infusion component, and a mechanical actuator. The fluid reservoir and the dosing mechanism are located in the housing, and the dosing mechanism is coupled to receive the medication fluid from the fluid reservoir. The dosing mechanism has an adjustable fluid chamber that defines a variable dosage volume. The infusion component is coupled to the dosing mechanism to receive the medication fluid from the adjustable fluid chamber. The mechanical actuator is coupled to the dosing mechanism such that operation of the mechanical actuator causes the medication fluid to be expelled from the adjustable fluid chamber to the infusion component.

In some aspects, the present invention provides cell-reactive compstatin analogs and compositions comprising cell-reactive compstatin analogs. In some aspects, the invention further provides methods of using cell-reactive compstatin analogs, e.g., treat a complement-mediated disorder, e.g., to inhibit complement-mediated damage to a cell, tissue, or organ. In some aspects, the invention provides long-acting compstatin analogs and compositions comprising long-acting compstatin analogs. In some aspects, the invention further provides methods of using long-acting compstatin analogs, e.g., to treat a complement-mediated disorder, e.g., to inhibit complement-mediated damage to a cell, tissue, or organ. In some aspects, the invention provides targeted compstatin analogs and compositions comprising targeted compstatin analogs. In some aspects, the invention further provides methods of using targeted compstatin analogs, e.g., to treat a complement-mediated disorder, e.g., to inhibit complement-mediated damage to a cell, tissue, or organ.

In some aspects, the present invention provides cell-reactive compstatin analogs and compositions comprising cell-reactive compstatin analogs. In some aspects, the invention further provides methods of using cell-reactive compstatin analogs, e.g., treat a complement-mediated disorder, e.g., to inhibit complement-mediated damage to a cell, tissue, or organ. In some aspects, the invention provides long-acting compstatin analogs and compositions comprising long-acting compstatin analogs. In some aspects, the invention further provides methods of using long-acting compstatin analogs, e.g., to treat a complement-mediated disorder, e.g., to inhibit complement-mediated damage to a cell, tissue, or organ. In some aspects, the invention provides targeted compstatin analogs and compositions comprising targeted compstatin analogs. In some aspects, the invention further provides methods of using targeted compstatin analogs, e.g., to treat a complement-mediated disorder, e.g., to inhibit complement-mediated damage to a cell, tissue, or organ.

A repeater system may control a pump by using a repeater and a user interface. An adhesive patch system may be used for affixing a pump or other object to a human body. Such an adhesive patch system may include two sets of adhesive members, each member including an adhesive material on at least one side so as to attach to the body. The members of the first set are spaced to allow the members of the second set to attach to the body in spaces provided between the members of the first set, and the members of the second set are spaced to allow members of the first set to detach from the body without detaching the members of the second set. Also, fill stations and base stations are provided for personal pump systems.

An infusion arrangement for administering a medical fluid includes a medical elastomer pump that produces a delivery pressure dependent on expansion and thus is variable over an infusion duration, a fluid conduit path provided for discharging the medical fluid from the elastomer pump, and a fluid control device arranged in the fluid conduit path and designed to influence a volumetric flow of the medical fluid delivered through the fluid conduit path by the elastomer pump. The fluid control device has a hydraulic flow-regulating valve designed to regulate the volumetric flow to a setpoint value and is provided with a throttle action that is automatically variable at least in accordance with the delivery pressure. The infusion arrangement can be used in infusion therapy.

An infusion arrangement for administering a medical fluid includes a medical elastomer pump that produces a delivery pressure dependent on expansion and thus is variable over an infusion duration, a fluid conduit path provided for discharging the medical fluid from the elastomer pump, and a fluid control device arranged in the fluid conduit path and designed to influence a volumetric flow of the medical fluid delivered through the fluid conduit path by the elastomer pump. The fluid control device has a hydraulic flow-regulating valve designed to regulate the volumetric flow to a setpoint value and is provided with a throttle action that is automatically variable at least in accordance with the delivery pressure. The infusion arrangement can be used in infusion therapy.

This document describes devices for in vivo drug testing in the brain. This document also describes implantable devices for long-term drug delivery to the brain parenchyma, and for access to biomarkers from the parenchyma.

This document describes devices for in vivo drug testing in the brain. This document also describes implantable devices for long-term drug delivery to the brain parenchyma, and for access to biomarkers from the parenchyma.

Methods and systems for infusing a user. An infusion pump includes a housing with an elastic component configured to expand and store potential energy. The infusion pump includes a first tube fluidically coupled to an outlet of the housing. The first tube is configured to conduct the fluid from the housing at a first flow rate. The infusion pump includes an air filter fluidically coupled to a distal end of the first tube via an air filter inlet. The infusion pump includes a second tube fluidically coupled to the air filter via an air filter outlet. The second tube is configured to adjust the first flow rate of the fluid conducted from the housing to a second flow rate. The infusion pump further includes one or more components for distributing the fluid to a user, the one or more components fluidically coupled to an outlet of the second tube.

A device for injecting contrast agent includes a supply line with a pressure regulator and leading to a soft injection bag in fluid communication with the supply line and with a catheter. The device also includes a pair of clamping plates acting on the injection bag and arranged on opposite sides of the injection bag. The clamping plates can be moves away from and close to each other. The device also includes a pair of inflatable compression bags. The compression bags are inflated with compressed air and act on corresponding clamping to plates to force the clamping plates to move close to each other and thus compress the injection bag. According to a method of the invention, the injection bag is filled from the source through the pressure regulator and a constant volume load container, and a contrast agent is supplied from the injection bag by gradually compressing the injection bag.